

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.75968561 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.75968561 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.55725906 |
| 4 | protein retention in ER lumen (GO:0006621) | 4.47736503 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.33333284 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.86706250 |
| 7 | pinocytosis (GO:0006907) | 3.84083868 |
| 8 | barbed-end actin filament capping (GO:0051016) | 3.83491209 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 3.81081073 |
| 10 | protein localization to endosome (GO:0036010) | 3.69047981 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 3.43379963 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.38436300 |
| 13 | glycosphingolipid catabolic process (GO:0046479) | 3.36175609 |
| 14 | proline biosynthetic process (GO:0006561) | 3.24955410 |
| 15 | mannose metabolic process (GO:0006013) | 3.24913185 |
| 16 | amyloid precursor protein catabolic process (GO:0042987) | 3.20260687 |
| 17 | skin morphogenesis (GO:0043589) | 3.18704464 |
| 18 | glycolipid catabolic process (GO:0019377) | 3.10942142 |
| 19 | amino sugar catabolic process (GO:0046348) | 3.09942332 |
| 20 | hyaluronan catabolic process (GO:0030214) | 3.03095546 |
| 21 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.02618883 |
| 22 | pentose-phosphate shunt (GO:0006098) | 3.02241984 |
| 23 | regulation of superoxide anion generation (GO:0032928) | 3.00966344 |
| 24 | basement membrane organization (GO:0071711) | 2.99111203 |
| 25 | nuclear envelope reassembly (GO:0031468) | 2.94802385 |
| 26 | mitotic nuclear envelope reassembly (GO:0007084) | 2.94802385 |
| 27 | response to peptidoglycan (GO:0032494) | 2.94440556 |
| 28 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.94291794 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 2.93652065 |
| 30 | apoptotic cell clearance (GO:0043277) | 2.91545242 |
| 31 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89287899 |
| 32 | cellular copper ion homeostasis (GO:0006878) | 2.87851478 |
| 33 | positive regulation of nuclease activity (GO:0032075) | 2.78742863 |
| 34 | glucose 6-phosphate metabolic process (GO:0051156) | 2.78023294 |
| 35 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.77054225 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 2.74937051 |
| 37 | glucose catabolic process (GO:0006007) | 2.73988950 |
| 38 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.73738555 |
| 39 | cell adhesion mediated by integrin (GO:0033627) | 2.73021669 |
| 40 | decidualization (GO:0046697) | 2.70407739 |
| 41 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68099781 |
| 42 | UV protection (GO:0009650) | 2.64717789 |
| 43 | modulation by symbiont of host cellular process (GO:0044068) | 2.64491682 |
| 44 | positive regulation of extracellular matrix organization (GO:1903055) | 2.63155677 |
| 45 | NADPH regeneration (GO:0006740) | 2.60800290 |
| 46 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59849325 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59438838 |
| 48 | adhesion of symbiont to host (GO:0044406) | 2.53456674 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.53110866 |
| 50 | cellular response to unfolded protein (GO:0034620) | 2.52673293 |
| 51 | ER-nucleus signaling pathway (GO:0006984) | 2.51859244 |
| 52 | ceramide catabolic process (GO:0046514) | 2.51367831 |
| 53 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.50136754 |
| 54 | response to thyroid hormone (GO:0097066) | 2.50107104 |
| 55 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.47765685 |
| 56 | regulation of nuclease activity (GO:0032069) | 2.46873223 |
| 57 | embryo implantation (GO:0007566) | 2.45553102 |
| 58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45416677 |
| 59 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45000354 |
| 60 | peptidyl-proline hydroxylation (GO:0019511) | 2.43158860 |
| 61 | regulation of cholesterol homeostasis (GO:2000188) | 2.41480127 |
| 62 | negative regulation of cell size (GO:0045792) | 2.38830943 |
| 63 | modulation by virus of host process (GO:0019054) | 2.38613174 |
| 64 | protein hydroxylation (GO:0018126) | 2.37778975 |
| 65 | membrane lipid catabolic process (GO:0046466) | 2.37663722 |
| 66 | cellular response to topologically incorrect protein (GO:0035967) | 2.37340475 |
| 67 | membrane raft organization (GO:0031579) | 2.36885852 |
| 68 | response to progesterone (GO:0032570) | 2.34838000 |
| 69 | sphingolipid catabolic process (GO:0030149) | 2.32999075 |
| 70 | adhesion of symbiont to host cell (GO:0044650) | 2.32049182 |
| 71 | virion attachment to host cell (GO:0019062) | 2.32049182 |
| 72 | cellular response to virus (GO:0098586) | 2.30744393 |
| 73 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.28951845 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.28888797 |
| 75 | pyrimidine-containing compound salvage (GO:0008655) | 2.28807066 |
| 76 | pyrimidine nucleoside salvage (GO:0043097) | 2.28807066 |
| 77 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.27975955 |
| 78 | stress fiber assembly (GO:0043149) | 2.25682446 |
| 79 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25395043 |
| 80 | proline metabolic process (GO:0006560) | 2.23312140 |
| 81 | regulation of cholesterol storage (GO:0010885) | 2.22684152 |
| 82 | regulation of early endosome to late endosome transport (GO:2000641) | 2.21875092 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.21038453 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.21038453 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.20762194 |
| 86 | hemidesmosome assembly (GO:0031581) | 2.20602514 |
| 87 | regulation of monocyte chemotaxis (GO:0090025) | 2.20567497 |
| 88 | cellular response to arsenic-containing substance (GO:0071243) | 2.20493886 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 2.18082568 |
| 90 | virion assembly (GO:0019068) | 2.18010175 |
| 91 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.17803923 |
| 92 | 4-hydroxyproline metabolic process (GO:0019471) | 2.17375714 |
| 93 | regulation of monocyte differentiation (GO:0045655) | 2.17278033 |
| 94 | fibril organization (GO:0097435) | 2.16833599 |
| 95 | N-acetylneuraminate metabolic process (GO:0006054) | 2.16374523 |
| 96 | endothelial cell chemotaxis (GO:0035767) | 2.16130767 |
| 97 | pentose metabolic process (GO:0019321) | 2.16052716 |
| 98 | type B pancreatic cell proliferation (GO:0044342) | 2.14409494 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.13890629 |
| 100 | regulation of metalloenzyme activity (GO:0048552) | 2.13839049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92432629 |
| 2 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70212056 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69361263 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43617061 |
| 5 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38507887 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35623066 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33954331 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29461638 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26635577 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.17045374 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99928767 |
| 12 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.99396282 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97255916 |
| 14 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.84425960 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.84050034 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78204065 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77152040 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69150309 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66209977 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57927357 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56653967 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56213688 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52730914 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52317199 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48864232 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47516589 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46756951 |
| 28 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46478552 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44071051 |
| 30 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42976930 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40191244 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38400254 |
| 33 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.37728281 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37569106 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36875381 |
| 36 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35011080 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34390542 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34354618 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33726104 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33509880 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33125611 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32297890 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31381857 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30796836 |
| 45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30059390 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.29939920 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28775286 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28752450 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28412883 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28084774 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28018124 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27967207 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25255291 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23555958 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23471358 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21834178 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21589778 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21555449 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21306286 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.21248237 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19748615 |
| 62 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19738669 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19565747 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19314288 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19198508 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18485165 |
| 67 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18468265 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17213580 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15718773 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14682794 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14517264 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14482997 |
| 73 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13041474 |
| 74 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12434920 |
| 75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12398381 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.11270117 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11192708 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11133859 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11054434 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09467689 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08503214 |
| 82 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08264101 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07825753 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07524545 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06954813 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06922901 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05812998 |
| 88 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.05221051 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03766046 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03630398 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03312144 |
| 92 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03021353 |
| 93 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02940092 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02649945 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02365395 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02340062 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02220774 |
| 98 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02139183 |
| 99 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.02103715 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02014570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.70307727 |
| 2 | MP0009840_abnormal_foam_cell | 4.00942393 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.33039746 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.97423959 |
| 5 | MP0005451_abnormal_body_composition | 2.90495867 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.74144543 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.53412747 |
| 8 | MP0003436_decreased_susceptibility_to | 2.53125343 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.42796068 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.20065797 |
| 11 | MP0008260_abnormal_autophagy | 2.16628853 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.15121496 |
| 13 | MP0006082_CNS_inflammation | 1.95986103 |
| 14 | MP0000858_altered_metastatic_potential | 1.89395077 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 1.88508138 |
| 16 | MP0004272_abnormal_basement_membrane | 1.82223569 |
| 17 | MP0003303_peritoneal_inflammation | 1.81912759 |
| 18 | MP0000604_amyloidosis | 1.74076137 |
| 19 | MP0009278_abnormal_bone_marrow | 1.72670855 |
| 20 | MP0005023_abnormal_wound_healing | 1.70093045 |
| 21 | MP0003075_altered_response_to | 1.70031711 |
| 22 | MP0004858_abnormal_nervous_system | 1.69027507 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.68701259 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.67574924 |
| 25 | MP0000343_altered_response_to | 1.65377154 |
| 26 | MP0004510_myositis | 1.61300741 |
| 27 | MP0004233_abnormal_muscle_weight | 1.60431264 |
| 28 | MP0002419_abnormal_innate_immunity | 1.55493353 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.55211723 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.50510445 |
| 31 | MP0003329_amyloid_beta_deposits | 1.50287165 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.49269115 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.46958396 |
| 34 | MP0001853_heart_inflammation | 1.46342385 |
| 35 | MP0003279_aneurysm | 1.46041240 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.38500196 |
| 37 | MP0005025_abnormal_response_to | 1.36110833 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.35884653 |
| 39 | MP0004947_skin_inflammation | 1.35447741 |
| 40 | MP0002060_abnormal_skin_morphology | 1.31035386 |
| 41 | MP0001849_ear_inflammation | 1.27116041 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.25645846 |
| 43 | MP0003091_abnormal_cell_migration | 1.25613924 |
| 44 | MP0009785_altered_susceptibility_to | 1.25471525 |
| 45 | MP0000685_abnormal_immune_system | 1.25462800 |
| 46 | MP0005165_increased_susceptibility_to | 1.19538333 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.16650511 |
| 48 | MP0001542_abnormal_bone_strength | 1.11839655 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.10520190 |
| 50 | MP0003448_altered_tumor_morphology | 1.10070563 |
| 51 | MP0002254_reproductive_system_inflammat | 1.09671454 |
| 52 | MP0008469_abnormal_protein_level | 1.09076291 |
| 53 | MP0002796_impaired_skin_barrier | 1.08211738 |
| 54 | MP0001873_stomach_inflammation | 1.06894859 |
| 55 | MP0001958_emphysema | 1.05003789 |
| 56 | MP0005390_skeleton_phenotype | 1.01508612 |
| 57 | MP0002089_abnormal_postnatal_growth/wei | 1.01360241 |
| 58 | MP0005164_abnormal_response_to | 1.01000895 |
| 59 | MP0005360_urolithiasis | 1.00462096 |
| 60 | MP0005501_abnormal_skin_physiology | 0.99809830 |
| 61 | MP0006054_spinal_hemorrhage | 0.98948499 |
| 62 | MP0001845_abnormal_inflammatory_respons | 0.98898174 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 0.98635402 |
| 64 | MP0001216_abnormal_epidermal_layer | 0.97834447 |
| 65 | MP0002452_abnormal_antigen_presenting | 0.97361976 |
| 66 | MP0005387_immune_system_phenotype | 0.96988391 |
| 67 | MP0001790_abnormal_immune_system | 0.96988391 |
| 68 | MP0001243_abnormal_dermal_layer | 0.95132095 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 0.90855390 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.89874727 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.89874727 |
| 72 | MP0010155_abnormal_intestine_physiology | 0.89484338 |
| 73 | MP0003950_abnormal_plasma_membrane | 0.88658488 |
| 74 | MP0005408_hypopigmentation | 0.88552311 |
| 75 | MP0002723_abnormal_immune_serum | 0.88200685 |
| 76 | MP0003795_abnormal_bone_structure | 0.88194649 |
| 77 | MP0002405_respiratory_system_inflammati | 0.84496284 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.82162053 |
| 79 | MP0005365_abnormal_bile_salt | 0.81404977 |
| 80 | MP0001881_abnormal_mammary_gland | 0.81359834 |
| 81 | MP0000490_abnormal_crypts_of | 0.81182856 |
| 82 | MP0001819_abnormal_immune_cell | 0.80513593 |
| 83 | MP0002420_abnormal_adaptive_immunity | 0.80154113 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.79783282 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.79279624 |
| 86 | MP0005166_decreased_susceptibility_to | 0.78607631 |
| 87 | MP0002933_joint_inflammation | 0.78584027 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.78316562 |
| 89 | MP0005621_abnormal_cell_physiology | 0.77097623 |
| 90 | MP0005310_abnormal_salivary_gland | 0.76706590 |
| 91 | MP0009764_decreased_sensitivity_to | 0.74824886 |
| 92 | MP0009931_abnormal_skin_appearance | 0.74405219 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.74223089 |
| 94 | MP0000609_abnormal_liver_physiology | 0.74160353 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.72604499 |
| 96 | MP0000371_diluted_coat_color | 0.67902807 |
| 97 | MP0000750_abnormal_muscle_regeneration | 0.67609254 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.66646433 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66029038 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.65616288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.51836333 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.51836333 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.51836333 |
| 4 | Vertebral compression fractures (HP:0002953) | 4.29273904 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.19854076 |
| 6 | Premature rupture of membranes (HP:0001788) | 4.13477357 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.92909921 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83464425 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.74620432 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20655009 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20655009 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20655009 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.13161969 |
| 14 | Loss of speech (HP:0002371) | 3.09835048 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07582722 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.07582722 |
| 17 | Achilles tendon contracture (HP:0001771) | 3.04162971 |
| 18 | Abnormality of the Achilles tendon (HP:0005109) | 2.83531874 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.82625842 |
| 20 | Axonal loss (HP:0003447) | 2.77143102 |
| 21 | J-shaped sella turcica (HP:0002680) | 2.74986627 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 2.70241500 |
| 23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67412997 |
| 24 | Nuclear cataract (HP:0100018) | 2.59040278 |
| 25 | Upper limb amyotrophy (HP:0009129) | 2.58510926 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 2.58510926 |
| 27 | Cervical subluxation (HP:0003308) | 2.57649106 |
| 28 | Increased serum ferritin (HP:0003281) | 2.54658704 |
| 29 | Amyloidosis (HP:0011034) | 2.50170207 |
| 30 | Hyperacusis (HP:0010780) | 2.40383683 |
| 31 | Myocardial infarction (HP:0001658) | 2.32686643 |
| 32 | Deep venous thrombosis (HP:0002625) | 2.31876049 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.30396696 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 2.29609410 |
| 35 | Short nail (HP:0001799) | 2.28716876 |
| 36 | Elbow flexion contracture (HP:0002987) | 2.28135806 |
| 37 | Trismus (HP:0000211) | 2.23017630 |
| 38 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.20805847 |
| 39 | Hand muscle atrophy (HP:0009130) | 2.20632035 |
| 40 | Rough bone trabeculation (HP:0100670) | 2.20046886 |
| 41 | Atrophic scars (HP:0001075) | 2.18973356 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 2.15484789 |
| 43 | Joint stiffness (HP:0001387) | 2.15468090 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.13183228 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.11406254 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.10579507 |
| 47 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10579507 |
| 48 | Blue sclerae (HP:0000592) | 2.05946450 |
| 49 | Xanthomatosis (HP:0000991) | 2.05421623 |
| 50 | Purpura (HP:0000979) | 2.05182959 |
| 51 | Fragile skin (HP:0001030) | 2.04456626 |
| 52 | Generalized amyotrophy (HP:0003700) | 2.01074413 |
| 53 | Hemorrhage of the eye (HP:0011885) | 1.97958725 |
| 54 | Hepatosplenomegaly (HP:0001433) | 1.96173479 |
| 55 | Pathologic fracture (HP:0002756) | 1.95349257 |
| 56 | Bone pain (HP:0002653) | 1.93339813 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 1.91208254 |
| 58 | Ulnar bowing (HP:0003031) | 1.90676203 |
| 59 | Abnormal trabecular bone morphology (HP:0100671) | 1.90378238 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 1.89612943 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 1.89380304 |
| 62 | Nonimmune hydrops fetalis (HP:0001790) | 1.88278041 |
| 63 | Spondylolisthesis (HP:0003302) | 1.87855204 |
| 64 | Cholecystitis (HP:0001082) | 1.86925485 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 1.86925485 |
| 66 | Vascular calcification (HP:0004934) | 1.85604209 |
| 67 | Cardiomegaly (HP:0001640) | 1.85121653 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 1.84850860 |
| 69 | Broad face (HP:0000283) | 1.84270921 |
| 70 | Abnormality of complement system (HP:0005339) | 1.83541165 |
| 71 | Cardiovascular calcification (HP:0011915) | 1.83396672 |
| 72 | Natal tooth (HP:0000695) | 1.82244045 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 1.81180830 |
| 74 | Thin bony cortex (HP:0002753) | 1.80847274 |
| 75 | Thoracic kyphosis (HP:0002942) | 1.80551808 |
| 76 | Hypokinesia (HP:0002375) | 1.79117453 |
| 77 | Hypertriglyceridemia (HP:0002155) | 1.78316021 |
| 78 | Wormian bones (HP:0002645) | 1.75857812 |
| 79 | Recurrent abscess formation (HP:0002722) | 1.74036504 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 1.73931562 |
| 81 | Hypertensive crisis (HP:0100735) | 1.73884715 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 1.72691696 |
| 83 | Flat acetabular roof (HP:0003180) | 1.72466813 |
| 84 | Ankle contracture (HP:0006466) | 1.70562021 |
| 85 | Abnormality of the thoracic spine (HP:0100711) | 1.70099785 |
| 86 | Increased connective tissue (HP:0009025) | 1.64461161 |
| 87 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.63107493 |
| 88 | Fasciculations (HP:0002380) | 1.62182101 |
| 89 | Petechiae (HP:0000967) | 1.61622971 |
| 90 | Mitral stenosis (HP:0001718) | 1.61228461 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 1.60673633 |
| 92 | Entropion (HP:0000621) | 1.59768116 |
| 93 | Long toe (HP:0010511) | 1.59567120 |
| 94 | Abnormality of the nasal mucosa (HP:0000433) | 1.58814454 |
| 95 | Progressive muscle weakness (HP:0003323) | 1.58814440 |
| 96 | Premature skin wrinkling (HP:0100678) | 1.57324204 |
| 97 | Biconcave vertebral bodies (HP:0004586) | 1.56782471 |
| 98 | Bladder diverticulum (HP:0000015) | 1.56374531 |
| 99 | Ovoid vertebral bodies (HP:0003300) | 1.55717640 |
| 100 | Coxa vara (HP:0002812) | 1.55696131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.41860175 |
| 2 | NME2 | 4.28520382 |
| 3 | IRAK3 | 3.94474178 |
| 4 | TRIB3 | 3.52884362 |
| 5 | TESK2 | 3.19234749 |
| 6 | TESK1 | 3.01272976 |
| 7 | EPHA2 | 2.93617808 |
| 8 | ICK | 2.36050569 |
| 9 | SMG1 | 2.33108284 |
| 10 | PIM2 | 2.24954782 |
| 11 | TAOK2 | 2.06468127 |
| 12 | SIK1 | 2.04271618 |
| 13 | LIMK1 | 1.91276423 |
| 14 | MAP3K11 | 1.88794197 |
| 15 | PAK4 | 1.88473715 |
| 16 | MAP3K3 | 1.83528035 |
| 17 | ARAF | 1.62599880 |
| 18 | MST1R | 1.56913810 |
| 19 | LMTK2 | 1.56549412 |
| 20 | TBK1 | 1.51901387 |
| 21 | PRPF4B | 1.44775988 |
| 22 | MAPKAPK3 | 1.43721265 |
| 23 | MAP2K3 | 1.43659964 |
| 24 | TGFBR2 | 1.42910815 |
| 25 | CDK12 | 1.40833087 |
| 26 | VRK2 | 1.37124530 |
| 27 | SCYL2 | 1.32567525 |
| 28 | PTK2 | 1.31039457 |
| 29 | ABL2 | 1.27820807 |
| 30 | RIPK1 | 1.18135727 |
| 31 | PKN2 | 1.16023886 |
| 32 | DDR2 | 1.15210561 |
| 33 | PDGFRA | 1.09611894 |
| 34 | PRKD2 | 1.09330272 |
| 35 | MOS | 1.07077440 |
| 36 | FGFR4 | 0.99442613 |
| 37 | EPHB1 | 0.98831819 |
| 38 | TAOK1 | 0.96196967 |
| 39 | TYK2 | 0.92022045 |
| 40 | MAP3K14 | 0.91757839 |
| 41 | CDC42BPA | 0.91497899 |
| 42 | EEF2K | 0.90482815 |
| 43 | BCKDK | 0.89765038 |
| 44 | TTN | 0.89582386 |
| 45 | KDR | 0.87660135 |
| 46 | MAPK11 | 0.87378139 |
| 47 | IRAK4 | 0.83318807 |
| 48 | ZAP70 | 0.81980772 |
| 49 | ILK | 0.78599000 |
| 50 | PTK6 | 0.77086620 |
| 51 | BLK | 0.74288366 |
| 52 | PDPK1 | 0.73250104 |
| 53 | MTOR | 0.73181914 |
| 54 | MAP3K13 | 0.71907629 |
| 55 | GRK7 | 0.71246109 |
| 56 | STK10 | 0.71080054 |
| 57 | MET | 0.69038768 |
| 58 | IKBKB | 0.68207319 |
| 59 | PDK2 | 0.66914651 |
| 60 | MAP3K1 | 0.66156104 |
| 61 | MAP3K8 | 0.61021196 |
| 62 | DAPK1 | 0.59619644 |
| 63 | PBK | 0.56901278 |
| 64 | BMX | 0.56065465 |
| 65 | LRRK2 | 0.56040548 |
| 66 | MAPKAPK2 | 0.54805339 |
| 67 | CDK7 | 0.54656445 |
| 68 | MAP4K1 | 0.54566141 |
| 69 | MATK | 0.54090192 |
| 70 | ERBB4 | 0.51720836 |
| 71 | JAK3 | 0.50270486 |
| 72 | RPS6KA2 | 0.49914224 |
| 73 | RPS6KB2 | 0.49644665 |
| 74 | SIK3 | 0.49187473 |
| 75 | IRAK2 | 0.48633185 |
| 76 | MAP2K2 | 0.43528356 |
| 77 | CLK1 | 0.42968731 |
| 78 | BRAF | 0.42711206 |
| 79 | CHUK | 0.42417878 |
| 80 | PAK2 | 0.41940449 |
| 81 | PRKG2 | 0.41270379 |
| 82 | GRK6 | 0.41027130 |
| 83 | CSK | 0.40696727 |
| 84 | NTRK1 | 0.40466139 |
| 85 | CDK8 | 0.40165000 |
| 86 | AURKA | 0.39899788 |
| 87 | EPHB2 | 0.38893914 |
| 88 | PAK1 | 0.37572805 |
| 89 | STK38 | 0.37485179 |
| 90 | HIPK2 | 0.36672197 |
| 91 | DAPK3 | 0.35941135 |
| 92 | MYLK | 0.34618392 |
| 93 | CSF1R | 0.34383742 |
| 94 | BUB1 | 0.34288426 |
| 95 | FGR | 0.34184321 |
| 96 | RPS6KC1 | 0.33770441 |
| 97 | RPS6KL1 | 0.33770441 |
| 98 | CAMK1D | 0.33657827 |
| 99 | CDK4 | 0.33515820 |
| 100 | IKBKE | 0.31828087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 5.00262919 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.48471312 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.26350549 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.79794469 |
| 5 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.36167983 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.26421453 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.08725790 |
| 8 | Bladder cancer_Homo sapiens_hsa05219 | 2.07904682 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.99809749 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.99070927 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 1.98500792 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.94216029 |
| 13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.81002210 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.75585002 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63962822 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.58047896 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50316648 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33612729 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31393837 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25640069 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24792181 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.24581195 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23793831 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.21260865 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20890805 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18487760 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.16249100 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15358910 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.14205280 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.11807926 |
| 31 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09606147 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09307713 |
| 33 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09187028 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06426382 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.06106704 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.02949162 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.02666419 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02170154 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00510631 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99732594 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.98303575 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98182226 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97991187 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97068861 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95737545 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94878523 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94831738 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93696319 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.93340364 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91167214 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.88187078 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85051763 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.82476553 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79238144 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.78831830 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78067414 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77657150 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77314569 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77048356 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76541684 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.76024758 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73848593 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70944006 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70646650 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66259186 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64735643 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61423768 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60796287 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60101178 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59867948 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59173105 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58836643 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58309962 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.57338226 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.56351587 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56171690 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53297949 |
| 78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52989414 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.52962867 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.52051299 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51853031 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49939911 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49687237 |
| 84 | DNA replication_Homo sapiens_hsa03030 | 0.48567450 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46012442 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44634618 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44611473 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44235025 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44203931 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44014266 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41644733 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40765977 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39604184 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39107688 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38031750 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37367112 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37167425 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37127700 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36932802 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36304954 |

